Health knowledge made personal

Health: Hearsay & Headlines

Fayetteville, Georgia
Health: Hearsay and Headlines (HHH) covers the entire spectrum of health issues. We touch on industry news, health news, medical issues, the latest findings and a wide assortment of related information. HHH is sponsored by the Georgia Front Page (.com) and is one of over 100 blogs we maintain.
› Share page:

Posts

Sort by: Most recent | Name
FDA begins process to remove breast cancer indication from Avastin label by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy The U.S. Food and Drug Administration announced today (December 16) that the agency is recommending removing the breast cancer indication from the label for Avastin (beva ... Read on »
Stroke Drops to Fourth Leading Cause of Death in 2008 by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- Stroke is now the fourth leading cause of death in the United States, down from the third place ranking it has held for decades, according to preliminary 200 ... Read on »
Oncologists Value Survival Over Quality of Life, Study Finds by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy For oncologists, drugs that help cancer patients live longer are worth more than drugs that help patients live well, according to research from Duke University's Fuqua Sc ... Read on »
Mayo Clinic Finds Seizure Generation in Brain is Isolated from Surrounding Brain Regions by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy Mayo Clinic researchers found that the part of the brain generating seizures in individuals with epilepsy is functionally isolated from surrounding brain regions. The res ... Read on »
UGA researchers identify key enzyme that regulates the early growth of breast cancer cells by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy New University of Georgia research, published this week in the early online edition of the journal Proceedings of the National Academy of Sciences, has found that blockin ... Read on »
New Low-Cost Method to Deliver Vaccine Shows Promise by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- Researchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is responsible for approxim ... Read on »
FDA Approves Xgeva to Help Prevent Cancer-Related Bone Injury by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication f ... Read on »
Doctors Ask Congress for Freedom, Not Bigger Reimbursements by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- Once again, the American Medical Association is begging Congress to postpone a fee cut for doctors under Medicare's "sustained growth rate" (SGR) method. Unl ... Read on »
Study: Starting with Chiropractic Saves 40% on Low Back Pain Care by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- New data from the Centers for Disease Control and Prevention (CDC) show that adults remain largely unvaccinated against preventable infectious illnesses. ... Read on »
NIH Awards $10 Million to Develop Microneedle Vaccine Patch by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy The National Institutes of Health (NIH) has awarded $10 million to the Georgia Institute of Technology, Emory University and PATH, a Seattle-based nonprofit organization, ... Read on »
New National Electronic Health Record Safety System Launched by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at leas ... Read on »
FDA approves Egrifta to treat Lipodystrophy in HIV patients by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different ... Read on »
New Magnetic Resonance Imaging (MRI) Data Show Efficacy of SIMPONI® in Treatment of... by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- Magnetic resonance imaging (MRI) analyses from two Phase 3 clinical trials showed that once every four week subcutaneous injections of SIMPONI® (golimumab ... Read on »
FDA clears Cymbalta to treat chronic musculoskeletal pain by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis a ... Read on »
Home-Based Mindfulness Treatment Curbs Depression in Adults With Epilepsy by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy A telephone- and Internet-delivered mindfulness-based depression treatment has been shown to significantly reduce depressive symptoms in adults with epilepsy, according t ... Read on »
FDA Approves Teflaro for Bacterial Infections by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy The U.S. Food and Drug Administration today (October 29) approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacteria ... Read on »
FDA approves Latuda to treat schizophrenia in adults by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia. Schizophrenia affects about 1 percent ... Read on »
FDA approves additional medical indication for Sprycel by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia. Schizophrenia affects about 1 pe ... Read on »
National Meningitis Association Statement on Advisory Committee on Immunization Practices Vote by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- On October 27, 2010, the CDC's Advisory Committee on Immunization Practices (ACIP) voted to expand the adolescent meningococcal vaccination recommendation ... Read on »
Patients Who Survive Sepsis Infections Are More Than Three Times as Likely to Develop Cognitive... by Health: Hearsay & Headlines Posted in: Blog Posts in Healthcare Industry & Policy /PRNewswire/ -- Older adults who survive severe sepsis are at higher risk for long-term cognitive impairment and physical limitations than those hospitalized for other re ... Read on »